SBI PRESS RELEASES FOR 1999   November 1, 1999 Structural Bioinformatics Inc. Elects New Board Member November 1, 1999 SBI Protein Models & Ligand Binding for Novel Viral Enzyme Validated August 23, 1999 Structural Bioinformatics Inc. Receives SBIR Grant to Discover Small-Molecule Drugs for Asthma Treatment August 11, 1999 Quest Diagnostics Incorporated and Structural Bioinformatics Inc. Announce Strategic Alliance For Pharmacogenomics Applications to Healthcare July 28, 1999 Structural Bioinformatics Inc. Announces Second Drug Discovery Collaboration with BioChem Pharma Inc. May 17, 1999 DuPont Pharmaceuticals Company and Structural Bioinformatics Inc. Announce $100M Strategic Alliance for Genes-to-Leads Projects May 13, 1999 Structural Bioinformatics Inc. Receives SBIR Grant to Develop Small-Molecule Inhibitors to Bacterial Metalloproteases May 6, 1999 Structural Bioinformatics Inc. Develops Small-Molecule Antagonists of Bcl-2 Gene Product, an Important Apoptosis-Related Protein Target in the Pathology of Human Cancers April 15, 1999 Structural Bioinformatics Inc. Receives SBIR Grant to Develop Small Molecule HER2 Antagonists Targeting Breast and Other Cancers March 16, 1999 Structural Bioinformatics Inc. Announces Gene-to-Lead Milestone in Collaboration with Yamanouchi Pharmaceutical Co., Ltd. February 16, 1999 Structural Bioinformatics Inc. Establishes European Sales and Marketing Operation